A total of 36 studies analyzed HBV-specific CD8+T cells in patients with HBV-associated HCC, of which 24 studies included circulating CD8+ T cells in PBMCs, and 26 studies analyzed infiltrating CD8+ T cells in liver tissue samples. Here, CD8A is linked to hepatocellular carcinoma.